Navigation Links
Neurocrine Biosciences Reports Second Quarter 2014 Results
Date:8/6/2014

on, the Company faces risks and uncertainties with respect to the rest of the Company's R & D pipeline including; risk that the Company's VMAT2 Phase III program will be delayed for regulatory or other reasons; risk that the VMAT2 Phase III clinical program will fail to demonstrate that NBI-98854 is safe and effective; risk that the guidance provided by the FDA in the End-of-Phase II meeting may be modified or may not lead to regulatory approval; risk that the Company will be unable to file an IND for Tourette syndrome or initiate clinical trials for regulatory or other reasons; risk that the Company's research programs will not identify pre-clinical candidates for further development; and  risk that the Company's other product candidates will not be found to be safe and effective.  With respect to its business overall, the Company faces risk that it will be unable to raise additional funding required to complete development of all of its product candidates; risk relating to the Company's dependence on contractors for clinical drug supply, commercial manufacturing and marketing and sales activities; uncertainties relating to patent protection and intellectual property rights of third parties; risks and uncertainties relating to competitive products and technological changes that may limit demand for the Company's products if approved.  The Company also faces the other risks described in the Company's annual report on Form 10-K for the year ended December 31, 2013 and quarterly report on Form 10-Q for the quarter ended March 31, 2014.  Neurocrine undertakes no obligation to update the statements contained in this press release after the date hereof.

 NEUROCRINE BIOSCIENCES, INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(in thousands, except per share data)(unaudited)Three Months Ended
June 30,Six Months Ended
June 30,2014'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
2. Neurocrine Biosciences Reports First Quarter 2012 Results
3. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
4. Neurocrine Biosciences Announces Conference Call And Webcast To Present Second Quarter 2012 Financial Results
5. Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference
6. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2012 Financial Results
7. Neurocrine Biosciences To Present At Lazard Capitalmarkets 9th Annual Healthcare Conference
8. Neurocrine Biosciences To Present At Deutsche Banks 2012 dbAccess BioFEST
9. Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor
10. Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial Results
11. Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 4, 2015  Hill-Rom Holdings, Inc. (NYSE: ... has been elected to its Board of Directors.  ... for Covidien, as well as President of Covidien,s Vascular ... Vascular from 2010 to 2012. Ms. Enxing ... of ev3 Incorporated, where she was a founding member ...
(Date:3/4/2015)... -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" ... company in China, today announced its financial results for ... Fourth Quarter 2014 Financial Highlights , ... by 36.2%, or 36.8% excluding the impact of foreign ... million in the same quarter of 2013. , ...
(Date:3/4/2015)... Calif. , March 4, 2015 Asterias ... in the emerging field of regenerative medicine, today announced ... Officer, will ring The Opening Bell ® of ... 5, 2015. Asterias began trading as an NYSE MKT ... "New York Stock Exchange is a trusted partner to ...
Breaking Medicine Technology:Hill-Rom Elects Stacy Enxing Seng to its Board of Directors 2China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 2China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 3China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 4China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 5China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 6China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 7China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 8China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 9China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 10China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 11China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 12China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 13China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 14China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 15China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 16China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 17China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 18China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 19China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 20China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 21China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 22Asterias Biotherapeutics to Ring Opening Bell at New York Stock Exchange 2Asterias Biotherapeutics to Ring Opening Bell at New York Stock Exchange 3
... is pleased to announce the addition of Suzie Williams , CP as ... Regional Clinical Manager.   , , ... http://www.newscom.com/cgi-bin/prnh/20100427/DA94114 ) , , , ... Suzie will be joining us as we were not only impressed by her ...
... & Reed Global Executive Search, a growing recruiting firm with offices worldwide, ... of Managing Director, Biopharmaceutical Life Sciences, effective April 15, 2010 . ... "Dave has outstanding ... recognize how important it is for our clients to work with a ...
Cached Medicine Technology:Suzie Williams, CP Joins Orthocare Innovations as Clinical Services Manager 2Kincannon & Reed Names David G. Jensen as Managing Director, Biopharma Life Sciences 2
(Date:3/5/2015)... March 05, 2015 New fiber fix heat ... TheHardwareCity.com is a one of a kind product, manufactured to ... received positively in its short time in the market by ... of broken fiber glass objects which cannot be done with ... commented, “We really are excited about our new product Fiber ...
(Date:3/5/2015)... TULSA, OK (PRWEB) March 05, 2015 ... been to build a faster, safer, smarter commercial lifting ... the company has an increasing role in more ... lifting systems last month – Octapad System for lifting ... place concrete barriers during road construction projects. , ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 March ... and information campaign sponsored by the Academy of ... into a Healthy Lifestyle," which promotes the consumption ... exercise for achieving and maintaining a healthy weight, ... wellness. , Whether a person is new ...
(Date:3/5/2015)... 05, 2015 Medical professionals suggest the ... it’s a crisis that is worsening. The demand for ... to stay on top of the physician shortage, health ... to meet face-to-face with physicians and advanced practitioners throughout ... Job Fair series. , Physician openings take an average ...
(Date:3/4/2015)... Nashville, Tenn. (PRWEB) March 04, 2015 Imagine ... to receive the Care2 Innovator Award , an honor ... was presented today at the Nonprofit Technology Conference ... pastor of Tarrytown United Methodist Church in Austin, was on ... Executive Committee for Imagine No Malaria. , Imagine No Malaria ...
Breaking Medicine News(10 mins):Health News:TheHardwareCity.com Launches New Fiber Fix Heat Wrap For High Temperature Applications 2Health News:New Vacuworx Concrete Lifting Systems Aid Safer, Greener Environment As Contractors Seek LEED Incentives 2Health News:New Vacuworx Concrete Lifting Systems Aid Safer, Greener Environment As Contractors Seek LEED Incentives 3Health News:National Nutrition Month® Tips for Athletes from the Austin Sports Medicine Team at Medicine in Motion 2Health News:National Nutrition Month® Tips for Athletes from the Austin Sports Medicine Team at Medicine in Motion 3Health News:Physician Shortage Crisis Worsening 2Health News:Imagine No Malaria Receives Care2 Innovator Award 2Health News:Imagine No Malaria Receives Care2 Innovator Award 3
... (BSGI), a,molecular breast imaging technique that is substantially ... comparable sensitivity for,detecting breast carcinoma when used in ... to findings presented today at the annual,meeting of ... "According to ...
... To help prevent the spread of germs and,protect its patients ... kill germs on hands and surfaces between cleanings. , ... LeAnna Grace, the hospital,conducted a 12-month research study of Germ ... well they work and was excited by the,results. , ...
... Md., Dec. 1 Vapotherm, the global leader in High ... Robert Storey, will present at Piper Jaffray,s annual health care ... New York Palace in Manhattan. , ... companies in the medical and health care sectors to present ...
... The following is a statement from Jeff Levi, Ph.D., ... to the Food and Drug Administration,s (FDA) progress report on ... "The nation lacks a real plan for food protection. ... moving forward with some key initiatives to improve food safety, ...
... COLUMBIA, S.C., Dec. 1 Welvista is pleased ... U.S., one of the world,s leading,pharmaceutical companies, to ... no-cost prescription medication program. With,the addition of ... (PAPs), Welvista now has 180 drugs on its ...
... EASTON, Mass., Dec. 1 Pressure BioSciences, Inc. (Nasdaq: ... comprehensive restructuring program designed to significantly reduce costs, centralize core ... where the Company,s products have found significant market acceptance. ... -- a reduction in personnel of eight full-time employees ...
Cached Medicine News:Health News:Molecular Breast Imaging Proves Cost-Effective for Presurgical Planning in Patients with Breast Cancer 2Health News:MRSA and C. difficile Infections Reduced by 50% in Hospital Study 2Health News:MRSA and C. difficile Infections Reduced by 50% in Hospital Study 3Health News:TFAH Statement: FDA Food Protection Plan is Insufficient 2Health News:Welvista Announces Partnering with sanofi-aventis U.S. to Provide Medication at No Cost to the Uninsured 2Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 2Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 3Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 4Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 5Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 6Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 7
... enables highly sensitive time-resolved fluorescence detection ... fluorophores. These compounds are excited with ... fluorescence lifetimes (several hundred microseconds), large ... profiles at 620 nm. Therefore with ...
... most advanced multi-functional microplate detection system, ... performance without compromising flexibility. ,The ... on the Ultra instrument platform. New ... adds to the flexibility of the ...
... OPTIMA is a fully automated microplate ... different measurement principles:, , Fluorescence Polarization ... Fluorescence , High-Performance Luminescence (flash ... ,It is designed for the ...
... FLUOstar is a flexible multifunction plate reader ... one instrument: fluorescence intensity, time-resolved fluorescence, high-perfomance ... be equipped with injectors that deliver reagent ... fast kinetic cell assays can be performed ...
Medicine Products: